Grant Skrepnek to Serotonin Uptake Inhibitors
This is a "connection" page, showing publications Grant Skrepnek has written about Serotonin Uptake Inhibitors.
Connection Strength
0.433
-
The cost-effectiveness of sertraline in the treatment of depression. Expert Opin Pharmacother. 2008 Oct; 9(14):2497-508.
Score: 0.300
-
Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial. Curr Med Res Opin. 2007 Feb; 23(2):245-50.
Score: 0.067
-
Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder. Curr Med Res Opin. 2007 Feb; 23(2):251-8.
Score: 0.067